Follow-The-Filings

Security

Caribou Biosciences Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners max 0.0% (Renaissance Technologies LLC)

owners 9
max % 0.0%
tracked value $20M
qoq A 4 R 3

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 2,590,497 $5M hist
Lee Ainslie - Maverick Capital Ltd 2026 Q1 0.0% 652,542 $1M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 4,304,198 $7M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 1,205,668 $2M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 1,074,421 $2M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 1,020,079 $2M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 187,622 $356 hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 159,033 $302 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 15,678 $30 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $34.48M $9.99M $11.16M
Gross profit
Gross margin
Net income -$102.07M -$149.1M -$148.12M
Net margin * -296.1% -1491.9% -1327.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $338.84M $219.38M $145.23M
Total non-current assets * $93.37M $93.94M $30.14M
Total assets $432.21M $313.31M $175.37M
Total current liabilities $28.3M $30.65M $25.41M
Total non-current liabilities * $35.51M $29.71M $27.78M
Total equity $368.4M $252.95M $122.18M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$93.29M -$138.2M -$110.99M
Cash from investing -$68.18M $86.61M $102.24M
Cash from financing $154.3M $16.72M $4.82M
Net change in cash -$7.18M -$34.87M -$3.93M

ownership over time

filing count by report period · click a bar for that quarter’s holders